{"id":"01a1df66-d42c-7337-bee2-8c0290648483","name":"NPPA trade margin cap on 137 non-scheduled anti-cancer drugs","situation_type":"regulatory_pressure","status":"active","start_date":"2026-10-17","end_date":null,"confidence":0.9,"member_count":3,"summary":"Three DGW event entities dated 2026-10-17 report the same regulatory development: NPPA capping the trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP. Two entries are typed as regulation and one as regulatory_action, with near-identical wording, indicating a single regulatory event recorded through multiple entity records rather than distinct developments.","place":"भारत","places":[{"name":"भारत","count":1}],"intensity":null,"unknowns":[],"known_at":"2026-11-15T13:30:20.582885Z","actors":[],"members":[{"kind":"event","id":"01a1df49-a499-78a3-9a71-2fd0b25c6d80","title":"NPPA caps trade margin on 137 non-scheduled anti-cancer drugs at 30% of MRP","type_code":"regulation","status":"completed","date":"2026-10-17","role":"part_of"},{"kind":"event","id":"01a1df4d-5923-7377-b92f-c5c9ed825898","title":"NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP","type_code":"regulation","status":"completed","date":"2026-10-17","role":"part_of"},{"kind":"event","id":"01a1df4e-8eb0-7e8f-92a7-80547c9aeafd","title":"NPPA caps trade margin on 137 non-scheduled anti-cancer medicines at 30% of MRP","type_code":"regulatory_action","status":"completed","date":"2026-10-17","role":"part_of"}],"evidence":null}